Loading clinical trials...
Loading clinical trials...
A Novel Distracted Driving Prevention Technology Phase II
The purpose of the study is to determine the efficacy of a smartphone app in reducing mobile phone use while driving among teens and parents. Prior to sending a message, the smartphone app informs a potential message sender that the recipient is driving.
The primary objective of this study is to determine whether the app reduces (1) smartphone communication sent from parent to teen while the teen is driving; and (2) smartphone communication sent from teen while the teen is driving. The secondary objectives are to: Determine whether the app reduces smartphone communication sent from teen to parent while parent is driving; Evaluate the acceptability of the app among parents and teens; and determine the relationship between individual differences (demographics, typical smartphone use, driving history, risk perception) and the app's efficacy.
Age
16 - 75 years
Sex
ALL
Healthy Volunteers
Yes
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
June 26, 2023
Primary Completion Date
July 23, 2024
Completion Date
July 23, 2024
Last Updated
May 6, 2025
500
ACTUAL participants
Intervention Bluetooth
OTHER
Intervention non-Bluetooth
OTHER
Control Bluetooth
OTHER
Control non-Bluetooth
OTHER
Lead Sponsor
Minnesota HealthSolutions
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions